Blue Harbour Interactive (08267.HK) announced that, according to the purchase authorization, the board of directors has been authorized and empowered to purchase cryptocurrencies in the open market for a maximum amount of up to $5 million. The nature of cryptocurrencies is usually highly volatile and is affected by sudden and significant price fluctuations. Since the approval of the purchase authorization on November 22, 2023, the value of cryptocurrencies has skyrocketed, making the purchase authorization's originally clear goals and final limitations on potential shareholder value increase unclear. In view of this situation, the company believes that it is necessary to revise the maximum amount to $6 million to purchase cryptocurrencies in the open market and further revise the upper limit of the unit price of Bitcoin and Ethereum not to exceed 10% of the market price. The board of directors believes that revising the purchase authorization can provide the board with flexibility to seize fleeting opportunities. Other terms of the purchase authorization will remain unchanged.

LK Venture, a subsidiary of Hong Kong listed company Blue Harbour Interactive, announced a comprehensive strategic partnership with Web3Labs, aiming to further strengthen investment and incubation in the Web3 field and jointly promote technological innovation and commercial applications in the industry.

Linekong Interactive, a Beijing-based gaming and film production company listed on the Hong Kong Stock Exchange, has announced a $15 million investment fund called "BTC Next" to support emerging projects in the Bitcoin ecosystem. The fund will focus on asset issuance protocols, trading markets, expansion, virtual machines, NFT, RWA, and GameFi. The company plans to participate in the research and investment of Bitcoin network ecological assets and update its investment portfolios accordingly. Linekong Interactive's founder, Wang Fang, resigned as CEO in 2018 to focus on blockchain and returned in 2022 to integrate Linekong products with Web3.